2019-2020

CHBRP generally analyzes introduced bills prior to their first Senate or Assembly Health Committee hearing. Completed CHBRP analyses (and the analyzed bill language) are available at http://chbrp.org/analysis/completed-analyses. As bills move through the Legislature, bills may be significantly amended, which may alter CHBRP’s projected impacts. The table, below, indicates the final version of each analyzed bill and the extent to which CHBRP’s analyses remain relevant. Final bill language and the bill status are available at http://leginfo.legislature.ca.gov/.

CHBRP’s analyses may still be of use after the legislative cycle concludes in order to inform future legislation, the implementation of analyzed legislation that is signed into law or included in California’s budget, and the ongoing evaluation of relevant health benefit mandates and repeals.

Bill Current location Bill amended since CHBRP analysis? Which portions of CHBRP’s analysis remain relevant?
AB 78
(Assembly Committee on Budget) Health: Actuarial Value
 Approved by the Governor – 6/27/19 Yes All portions of CHBRP’s analysis remains relevant.
AB 166
(Gabriel) Medi-Cal: violence preventive services
 Vetoed by the Governor – 10/13/19 Yes Bill was amended in June to direct the Department of Health Care Services to establish a violence prevention pilot program with a minimum of at least one site in each of 9 counties. The Background, Medical Effectiveness, and portions of the public health impact sections remain relevant.
AB 598
(Bloom) Hearing Aids
 Held at Desk – 9/13/19 Yes CHBRP’s original analysis remains largely relevant. A dollar cap was placed on coverage of hearing aids ($3,000), however CHBRP projected average hearing aid costs of $1,825 in its cost projections. The bill also would allow coverage for ear mold fittings every 4 years instead of 5; no significant impact is expected and CHBRP’s estimates remain relevant. Further amendments were made on July 2nd. The first substantive amendment would require the contracted providers to include a pediatric audiologist for children under 5 years of age. The second amendment would require that hearing aids covered by AB 598 be subject to the cost sharing imposed by the plan contract for durable medical equipment. The overall cost projections in CHBRP’s analysis are still relevant, however some modest reduction in projected premium costs could be anticipated in light of the potentially higher deductibles that some enrollees might incur given the amendment on July 2nd around cost sharing.
AB 651
(Grayson) Air Ambulance Services
 Approved by the Governor – 10/7/19 Yes CHBRP’s analysis of the impact of the bill for enrollees in commercial insurance and CalPERS remains relevant. However, the amended language would alter the impacts related to Medi-Cal beneficiaries, making impacts related to that group uncertain.
AB 744
(Aguiar-Curry) Telehealth
 Approved by the Governor – 10/13/19 Yes Bill amended to delay effective date to January 1, 2021. CHBRP analysis provided impacts for 2020, but fiscal impacts will be similar in 2021. All other portions of CHBRP’s analysis remains relevant.
AB 767
(Wicks) Infertility
 Senate Health Committee hearing canceled at the request of author –7/8/19 Yes Bill amended to require Covered California to develop options for the inclusion of in vitro fertilization coverage to coverage offered through the marketplace. The Background, Medical Effectiveness, and portions of the public health impacts sections remain relevant.
AB 993
(Nazarian) Health Care Coverage: HIV Specialists
 Vetoed by the Governor – 10/12/19 Yes All portions of CHBRP’s analysis remains relevant.
AB 1246
(Limón) Basic Health Care Services
 Held under submission in Senate Appropriations Committee – 8/30/19 Yes All portions of CHBRP’s analysis remains relevant.
AB 1611
(Chiu) Emergency Hospital Services: Costs
 Senate Health Committee hearing canceled at the request of author – 7/10/19 Yes Technical amendments were made to the bill, and Medi-Cal was specifically excluded. However CHBRP had already interpreted the bill in its original form to exclude MediCal. All portions of CHBRP’s fiscal analysis remains relevant.
AB 1676
(Maienschein) Mental Health
 Held under submission in Assembly Appropriations Committee – 5/16/19 Yes Bill now defines telehealth and telehealth video services as excluding email. Portions of CHBRP’s medical effectiveness and public health findings remain relevant.
AB 1904
(Boerner Horvath) Pelvic Floor Physical Therapy
 Died in Assembly Health Committee No initial health committee hearing scheduled No All portions of CHBRP’s analysis remain relevant.
AB 1986
(Gipson) Colorectal Cancer Screening and Testing
 Died in Assembly Health Committee No initial health committee hearing scheduled No All portions of CHBRP’s analysis remain relevant.
AB 2144
(Arambula) Step Therapy and Prior Authorization
 Died in Assembly Health Committee No initial health committee hearing scheduled No All portions of CHBRP’s analysis remain relevant.
AB 2203
(Nazarian) Insulin Cost-Sharing Cap
 Died in Senate Health Committee Yes All portions of CHBRP’s analysis remain relevant.
AB 2204
(Arambula) Sexually Transmitted Diseases
 Died in Assembly Health Committee No initial health committee hearing scheduled No All portions of CHBRP’s analysis remain relevant.
AB 2242
(Levine) Mental Health Services
 Died in Assembly Health Committee No initial health committee hearing scheduled No All portions of CHBRP’s analysis remain relevant.
AB 2258
(Reyes, Bonta, Limón, McCarty) Doula Care: Medi-Cal Pilot Program
 Died in Assembly Health Committee No initial health committee hearing scheduled No All portions of CHBRP’s analysis remain relevant.
AB 2625
(Boerner Horvath) Emergency Ground Medical Transportation
 Died in Assembly Health Committee No initial health committee hearing scheduled No All portions of CHBRP’s analysis remain relevant.
AB 2781
(Wicks) Treatment for Infertility
 Died in Assembly Health Committee No initial health committee hearing scheduled No All portions of CHBRP’s analysis remain relevant.
SB 11
(Beall) Mental Health Parity and Substance Use Medications
 Held under submission in Senate Appropriations Committee – 5/16/19 Yes All portions of CHBRP’s analysis remain relevant.
SB 159
(Wiener) HIV Prophylaxis
 Approved by the Governor – 10/7/19 Yes Bill now requires coverage of pharmacists independently furnishing an initial supply of PrEP of at least 30 days and up to 60 days. An updated cost impact analysis was provided to Senate Appropriations on 5/8/2019 reflecting prior amendments requiring coverage of pharmacists independently furnishing an initial 30-day supply of PrEP and is available on CHBRP’s website. Fiscal impacts reflecting the subsequent amendments would be similar to the previous two fiscal analyses. CHBRP’s medical effectiveness review remains relevant and most of the public health and long term impacts.
SB 163
(Portantino) Autism
 Vetoed by the Governor – 10/12/19 Yes All portions of CHBRP’s analysis remains relevant.
SB 583
(Jackson) Clinical Trials
 Approved by the Governor – 10/2/19 Yes All portions of CHBRP’s analysis remains relevant.
SB 600
(Portantino) Fertility Preservation
 Approved by the Governor – 10/12/19 Yes Bill now states that standard fertility preservation services are a basic health care service. SB 600 now only applies to DMHC-regulated plans and does not apply to CDI regulated policies or Medi-Cal Managed Care plans. The CHBRP medical effectiveness findings remains relevant. The cost and public health impacts projected for DMHC regulated plans remain relevant.
SB 746
(Bates) Anticancer Medical Devices
 Held under submission in Assembly Appropriations Committee – 8/30/19 Yes All portions of CHBRP’s analysis remains relevant.
SB 854
(Beall) Substance Use Disorders
 Died in Senate Health Committee No initial health committee hearing scheduled Yes The Medical Effectiveness and Policy Context sections remain fully relevant. Impacts projected for Benefit Coverage, Cost, Utilization and Public Health remain accurate in scale and direction.
SB 855
(Wiener) Mental Health Parity
 Approved by the Governor – 9/25/20 Yes Overall, all portions of CHBRP’s analysis remain relevant. While specific discussions regarding aspects of bill language may only be partially relevant due to the amendments (medical necessity, utilization management, clinical guidelines, levels of care), the overall impacts remain relevant.
SB 888
(Wiener) Substance Use Disorder Services: Contingency Management
 Died in Senate Health Committee No initial health committee hearing scheduled. No All portions of CHBRP’s analysis remain relevant.
SB 1452
(Morrell) Biological Products
 Died in Senate Health Committee No initial health committee hearing scheduled No All portions of CHBRP’s analysis remain relevant.